Pathogenesis of duodenal ulcer disease.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D000681:Amylases / Q000378:metabolism; D000818:Animals; D001923:Brain Chemistry; D003543:Cysteamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004381:Duodenal Ulcer / Q000453:epidemiology* / Q000517:prevention & control; D004386:Duodenum / Q000648:ultrastructure; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism; D005755:Gastrins / Q000502:physiology; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006728:Hormones / Q000502:physiology; D006801:Humans; D051379:Mice; D009570:Nitriles / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012633:Secretin / Q000502:physiology; D009626:Terminology as Topic; D014629:Vagotomy, Proximal Gastric; D015043:Zollinger-Ellison Syndrome / Q000150:complications
D005755:Gastrins; D006635:Histamine H2 Antagonists; D006728:Hormones; D009570:Nitriles; D015102:3,4-Dihydroxyphenylacetic Acid; D012633:Secretin; D003543:Cysteamine; C005557:propionitrile; D000681:Amylases; D004298:Dopamine; D009638:Norepinephrine